First batch of Sputnik V vaccine to arrive in Kanpur medical college for Phase 2, 3 trials
The first batch of Russia’s Sputnik V vaccine for Covid-19 is likely to reach Kanpur’s Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine’s Phase 2 and Phase 3 human clinical trials will be conducted.
The decision to conduct the human clinical trials of the vaccine was taken after Dr Reddy’s Laboratories got approval from the Drugs Controller General of India (DCGI) in this regard, an official said. Speaking to PTI, college principal R B Kamal said the human clinical trials of the vaccine will start from next week.
“As many as 180 volunteers have registered for the trials. Head of the research Saurabh Agarwal will determine the dosage of the vaccine to be administered. One dose will be administered and the condition of volunteers will be monitored to determine whether they need further doses or not,” he said. Kamal said the volunteers’ vitals and condition will be checked periodically and the data will be analysed to determine whether the vaccine is a success or not.
Read more | 250 register for Covid vaccine trial at AMU
He said the effect of the vaccine on the volunteers will be studied for seven months after the same is administered once, twice or thrice within an interval of 21 days. After observing the effects of the vaccine for a month, authorities will be apprised of the results of the trial and they will then make a decision accordingly.
The ethics Committee of the college has also given permission for the trails, he said. The vaccine has to be kept at a temperature of -20 to -70 degrees Celsius. In September, Dr Reddy’s and the Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India. As part of the partnership, RDIF shall supply 100 million doses of the vaccine to Dr Reddy’s upon regulatory approval in India. On August 11, the Sputnik V vaccine was registered by the Ministry of Health of Russia and became the world’s first registered vaccine against Covid-19 based on the human adenoviral vector platform.
On November 15, India’s Covid-19 tally reached 88,14,579 as the country reported a spike of 41,100 new cases while 447 succumbed to the disease.
Enter your email to get our daily newsletter in your inbox
- The parliament canteen, now run by ITDC will offer as many as 58 items, both vegetarian and non-vegetarian, from January 27.
- Union minister for culture and tourism Prahlad Patel said government is addressing the lack of adventure sports equipment in Kargil.
- In contrast to the violence seen in the Capital, farmers held peaceful rallies across the country to protest against the farm laws.
- India put on display its war machines at a time when the country is locked in a tense border stand-off with China.
- The chaos and violence have raised questions about the future of the two-month-long agitation of farm unions.
- Bangladesh Prime Minister Sheikh Hasina, in a letter sent to her Indian counterpart, conveyed her greetings.
- Tuesday's decision to operate all trains comes a day after a meeting to resume local train services for all passengers was chaired by Maharashtra chief minister Uddhav Thackeray.
- Khattar said that unsavoury events on Tuesday deserved to be condemned in the strongest words.
- Governor RN Ravi said 'politics by gun' has stonewalled efforts to resolve the Naga political issue.
- No details were shared about the meeting, although a functionary said the party sees similarities in Tuesday’s protests with last year's anti-CAA agitation.